Acer Therapeutics (ACER) Reports FDA Acceptance of NDA and Priority Review for EDSIVO for Treatment of vEDS - https://t.co/gM21sWkdr3 https://t.co/G0lnHMIV4Z
— IDRO (@IDROOhio) December 26, 2018
from Twitter https://twitter.com/IDROOhio
December 26, 2018 at 09:52AM
No comments:
Post a Comment